BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25803871)

  • 1. Optimal strategies for controlling riverine tsetse flies using targets: a modelling study.
    Vale GA; Hargrove JW; Lehane MJ; Solano P; Torr SJ
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003615. PubMed ID: 25803871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelled impact of Tiny Targets on the distribution and abundance of riverine tsetse.
    Vale GA; Hargrove JW; Hope A; Torr SJ
    PLoS Negl Trop Dis; 2024 Apr; 18(4):e0011578. PubMed ID: 38626189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the even distribution of insecticide-treated cattle essential for tsetse control? Modelling the impact of baits in heterogeneous environments.
    Torr SJ; Vale GA
    PLoS Negl Trop Dis; 2011 Oct; 5(10):e1360. PubMed ID: 22028944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baited-boats: an innovative way to control riverine tsetse, vectors of sleeping sickness in West Africa.
    Rayaisse JB; Salou E; Courtin F; Yoni W; Barry I; Dofini F; Kagbadouno M; Camara M; Torr SJ; Solano P
    Parasit Vectors; 2015 Apr; 8():236. PubMed ID: 25928366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivering 'tiny targets' in a remote region of southern Chad: a cost analysis of tsetse control in the Mandoul sleeping sickness focus.
    Rayaisse JB; Courtin F; Mahamat MH; Chérif M; Yoni W; Gadjibet NMO; Peka M; Solano P; Torr SJ; Shaw APM
    Parasit Vectors; 2020 Aug; 13(1):419. PubMed ID: 32795375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost of tsetse control using 'Tiny Targets' in the sleeping sickness endemic forest area of Bonon in Côte d'Ivoire: Implications for comparing costs across different settings.
    Courtin F; Kaba D; Rayaisse JB; Solano P; Torr SJ; Shaw APM
    PLoS Negl Trop Dis; 2022 Jan; 16(1):e0010033. PubMed ID: 34986176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sequential aerosol technique: a major component in an integrated strategy of intervention against Riverine Tsetse in Ghana.
    Adam Y; Cecchi G; Kgori PM; Marcotty T; Mahama CI; Abavana M; Anderson B; Paone M; Mattioli R; Bouyer J
    PLoS Negl Trop Dis; 2013; 7(3):e2135. PubMed ID: 23516662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards an optimal design of target for tsetse control: comparisons of novel targets for the control of Palpalis group tsetse in West Africa.
    Rayaisse JB; Esterhuizen J; Tirados I; Kaba D; Salou E; Diarrassouba A; Vale GA; Lehane MJ; Torr SJ; Solano P
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1332. PubMed ID: 21949896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of improved coloured targets to control riverine tsetse in East Africa: A Bayesian approach.
    Santer RD; Okal MN; Esterhuizen J; Torr SJ
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009463. PubMed ID: 34153040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost analysis of options for management of African Animal Trypanosomiasis using interventions targeted at cattle in Tororo District; south-eastern Uganda.
    Muhanguzi D; Okello WO; Kabasa JD; Waiswa C; Welburn SC; Shaw AP
    Parasit Vectors; 2015 Jul; 8():387. PubMed ID: 26198109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the costs of tsetse control options: an example for Uganda.
    Shaw AP; Torr SJ; Waiswa C; Cecchi G; Wint GR; Mattioli RC; Robinson TP
    Prev Vet Med; 2013 Jul; 110(3-4):290-303. PubMed ID: 23453892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the cost-effectiveness of visual devices for the control of riverine tsetse flies, the major vectors of human African trypanosomiasis.
    Esterhuizen J; Rayaisse JB; Tirados I; Mpiana S; Solano P; Vale GA; Lehane MJ; Torr SJ
    PLoS Negl Trop Dis; 2011 Aug; 5(8):e1257. PubMed ID: 21829743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding tsetse control to medical activities contributes to decreasing transmission of sleeping sickness in the Mandoul focus (Chad).
    Mahamat MH; Peka M; Rayaisse JB; Rock KS; Toko MA; Darnas J; Brahim GM; Alkatib AB; Yoni W; Tirados I; Courtin F; Brand SPC; Nersy C; Alfaroukh IO; Torr SJ; Lehane MJ; Solano P
    PLoS Negl Trop Dis; 2017 Jul; 11(7):e0005792. PubMed ID: 28750007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs of using "tiny targets" to control Glossina fuscipes fuscipes, a vector of gambiense sleeping sickness in Arua District of Uganda.
    Shaw AP; Tirados I; Mangwiro CT; Esterhuizen J; Lehane MJ; Torr SJ; Kovacic V
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003624. PubMed ID: 25811956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the impact of Tiny Targets in reducing the incidence of Gambian sleeping sickness in the North-west Uganda focus.
    Bessell PR; Esterhuizen J; Lehane MJ; Longbottom J; Mugenyi A; Selby R; Tirados I; Torr SJ; Waiswa C; Wamboga C; Hope A
    Parasit Vectors; 2021 Aug; 14(1):410. PubMed ID: 34407867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tsetse Control and Gambian Sleeping Sickness; Implications for Control Strategy.
    Tirados I; Esterhuizen J; Kovacic V; Mangwiro TN; Vale GA; Hastings I; Solano P; Lehane MJ; Torr SJ
    PLoS Negl Trop Dis; 2015; 9(8):e0003822. PubMed ID: 26267814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of vector control to protect people from sleeping sickness in the focus of Bonon (Côte d'Ivoire).
    Kaba D; Djohan V; Berté D; Ta BTD; Selby R; Kouadio KAM; Coulibaly B; Traoré G; Rayaisse JB; Fauret P; Jamonneau V; Lingue K; Solano P; Torr SJ; Courtin F
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009404. PubMed ID: 34181651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tiny targets on Glossina fuscipes quanzensis, the primary vector of human African trypanosomiasis in the Democratic Republic of the Congo.
    Tirados I; Hope A; Selby R; Mpembele F; Miaka EM; Boelaert M; Lehane MJ; Torr SJ; Stanton MC
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008270. PubMed ID: 33064783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tsetse elimination: its interest and feasibility in the historical sleeping sickness focus of Loos islands, Guinea.
    Kagbadouno M; Camara M; Bouyer J; Hervouet JP; Courtin F; Jamonneau V; Morifaso O; Kaba D; Solano P
    Parasite; 2009 Mar; 16(1):29-35. PubMed ID: 19353949
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scaling up of tsetse control to eliminate Gambian sleeping sickness in northern Uganda.
    Hope A; Mugenyi A; Esterhuizen J; Tirados I; Cunningham L; Garrod G; Lehane MJ; Longbottom J; Mangwiro TC; Opiyo M; Stanton M; Torr SJ; Vale GA; Waiswa C; Selby R
    PLoS Negl Trop Dis; 2022 Jun; 16(6):e0010222. PubMed ID: 35767572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.